Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

计划入组 16 人 · 首次发布于 2020 年 9 月 2 日

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

计划入组 90 人 · 首次发布于 2011 年 10 月 26 日

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

计划入组 132 人 · 首次发布于 2017 年 11 月 6 日

CDX/CD3

CDX-303

CDX-602

Complete Care Inc

Canada

Tissue Genesis

United States

Complete Care Medical, Inc.

United States

Labcorp's PGDx elio Tissue Complete CDx Gains FDA Approval as Companion Diagnostic for BRAF-Mutant Advanced Melanoma

Labcorp Expands Precision Oncology Portfolio with Advanced Liquid Biopsy and MRD Testing Solutions

FDA Issues Complete Response Letter for Telix's Kidney Cancer Imaging Agent TLX250-CDx